Massachusetts-based AI precision medicine company Iterative Scopes has raised USD 150 million in a Series B funding round co-led by Insight Partners and Clearlake Capital Group. Other investors including Obvious Ventures and Johnson & Johnson Innovation also participated in the round. The round follows the company’s recent USD 30 million Series A funding round in August 2021.
The proceeds will be directed toward developing the company’s AI-driven technologies further to expand its product offerings as well as grow its technical and clinical operations teams.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.